Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Wellnex LifeASX:WNX +1.09% Revenue per Share is A$0.59 as of Dec. 2025. The stock has 2 warning signs investors should review. Among 1,841 Consumer Packaged Goods companies, Wellnex Life ranks worse than 95% on this metric.
Wellnex Life's revenue per share for the
six
months ended in Dec. 2025 was A$0.19.
Wellnex Life's revenue per share for the trailing twelve months (TTM) ended in Dec. 2025 was A$0.59.
Warning Sign:
Wellnex Life Ltd revenue per share has been in decline over the past 3 years.
During the past 12 months, the average Revenue Per Share Growth Rate of Wellnex Life was -28.60% per year.
During the past 3 years, the average Revenue Per Share Growth Rate was -27.30% per year.
During the past 5 years, the average Revenue Per Share Growth Rate was 50.70% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate.
The historical rank and industry rank for Wellnex Life's Revenue per Share or its related term are showing as below:
ASX:WNX'
s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -30.9 Med: 28.15 Max: 170.5
Current: -27.3
During the past 9 years, Wellnex Life's highest 3-Year average Revenue Per Share Growth Rate was 170.50% per year. The lowest was -30.90% per year. And the median was 28.15% per year.
ASX:WNX's 3-Year Revenue Growth Rate is ranked worse than 95% of 1841
companies
in the Consumer Packaged Goods industry
Industry Median: 3.6
vs ASX:WNX: -27.30
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
Wellnex Life Revenue per Share Related Terms
Wellnex Life Revenue per Share Historical Data
* Premium members only.
The historical data trend for Wellnex Life's Revenue per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Packaged Foods subindustry, Wellnex Life's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Wellnex Life PS Ratio vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Wellnex Life's PS Ratio distribution charts can be found below:
* The bar in red indicates where Wellnex Life's PS Ratio falls into.
Revenue per Share is the amount of Revenue per outstanding share of the company's stock.
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Wellnex Life's Revenue Per Share for the fiscal year that ended in Jun. 2025 is calculated as
Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.59
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Wellnex Life (ASX:WNX) has a Revenue per Share of A$0.59 as of Dec. 2025. Revenue per share equals the per-share value of a company's sales. View historical data on Wellnex Life and its competitors. According to the industry distribution chart, Wellnex Life ranks #1749 out of 1841 companies in the Consumer Packaged Goods industry, placing it in the top 95%.
Is Wellnex Life's Revenue per Share too high?
Wellnex Life's current Revenue per Share is A$0.59. Based on the distribution chart, Wellnex Life ranks #1749 out of 1841 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers.
How does Wellnex Life's Revenue per Share compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Wellnex Life ranks #1749 out of 1841 companies for Revenue per Share. This places Wellnex Life in the lower half of its industry. The industry median Revenue per Share is 3.60. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue per Share for a Consumer Packaged Goods company?
The median Revenue per Share among Consumer Packaged Goods companies is 3.60, based on 1,841 companies in the industry. Companies in the top quartile (top 25%) have a Revenue per Share significantly above this median, while those in the bottom quartile fall well below. However, Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue per Share mean?
A high Revenue per Share can signal that a stock is expensive relative to its fundamentals. Revenue per share equals the per-share value of a company's sales. View historical data on Wellnex Life and its competitors. For the Consumer Packaged Goods industry, the median Revenue per Share is 3.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Wellnex Life's current Revenue per Share is A$0.59. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Wellnex Life stock overvalued right now?
Based on GuruFocus' analysis, Wellnex Life (ASX:WNX) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.36, compared to a current price of A$0.09 — trading 74.2% below its estimated fair value. The current Revenue per Share is A$0.59. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue per Share calculated?
Revenue per Share is calculated from a company's financial statements. For Wellnex Life (ASX:WNX), the current Revenue per Share is A$0.59 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Wellnex Life Ltd is a consumer healthcare company focused on developing, licensing, marketing, and distributing healthcare and pharmaceutical products. These products are available mainly through Australian retailers and wholesalers, including Coles, Woolworths, Chemist Warehouse, Sigma, and Symbion. The group's offerings include caffeine energy liquid capsules, multivitamins, pain relief creams and sprays, sleep aids, toothpaste, over-the-counter medicines, and medical cannabis products, among others. Its brands include Pharmacy Own, Wellness Life, Mr. Bright, Pain Away, Nighty Night, Wakey Wakey, and Wagner Health Liquigesic. Geographically, the majority of the group's revenue comes from Australia, with additional contributions from the United Kingdom and New Zealand.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:WNX has been successfully added to your 
